CIK 0001213037 · Non-accelerated filer<br>Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272004382
- Phone
- 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-14 | PACE GARY W Director | Purchase | +687,285 | $1.46 | $1000K | 2,043,661 |
| 2026-07-14 | PACE GARY W Director | Purchase · Common Stock Purchase Warrant | +687,285 | 687,285 | ||
| 2026-07-14 | Mohindru Mani Chief Executive Officer | Purchase | +34,364 | $1.46 | $50K | 59,067 |
| 2026-07-14 | Mohindru Mani Chief Executive Officer | Purchase · Common Stock Purchase Warrant | +34,364 | 34,364 | ||
| 2026-06-18 | Mohindru Mani Chief Executive Officer | Purchase | +24,703 | $1.21 | $30K | 24,703 |
| 2026-06-18 | PACE GARY W Director | Purchase | +30,000 | $1.22 | $37K | 1,356,376 |
| 2026-06-11 | White Lale Director | Grant or award · Stock Options | +40,565 | 199,246 | ||
| 2026-06-11 | TANNENBAUM RENEE P Director | Grant or award · Stock Options | +40,565 | 209,331 | ||
| 2026-06-11 | Markin Rodney S Director | Grant or award · Stock Options | +40,565 | 263,430 | ||
| 2026-06-11 | Armitage James O Director | Grant or award · Stock Options | +40,565 | 228,104 | ||
| 2026-06-11 | PACE GARY W Director | Grant or award · Stock Options | +40,565 | 228,104 | ||
| 2026-04-27 | Aggarwal Ajay Chief Operating Officer | Grant or award · Stock Options | +400,000 | 400,000 | ||
| 2026-04-14 | Smeal Tod Chief Scientific Officer | Grant or award · Stock Options | +300,000 | 1,279,805 | ||
| 2026-04-06 | Muntner Joshua B Chief Financial Officer | Grant or award · Stock Options | +486,650 | 487,150 | ||
| 2026-04-06 | Muntner Joshua B Chief Financial Officer | Grant or award · Stock Options | +486,650 | 487,150 | ||
| 2026-03-31 | Mohindru Mani Chief Executive Officer | Grant or award · Stock Options | +600,000 | 968,766 | ||
| 2026-02-17 | Mohindru Mani Interim CEO | Grant or award · Stock Options | +200,000 | 368,766 | ||
| 2026-02-13 | Lindsay Brigitte Ute Chief Accounting Officer | Grant or award · Stock Options | +200,000 | 1,025,334 | ||
| 2025-07-30 | PACE GARY W Director | Purchase | +275,000 | $2.45 | $674K | 1,330,676 |
| 2025-07-30 | PACE GARY W Director | Purchase | +15,000 | $2.45 | $37K | 1,345,676 |
Page 1 of 8 · 144 trades